We have also observed diminished activation of NF-kB not only in keratinocytes but in K5-CYLDwt/TgAC tumors, which is very relevant, since diminished NF-κB signaling inhibits responses such as inflammation, cell proliferation, and angiogenesis, which cause tumor development and progression [43]. The gene discussed is NFKB1; the disease is neoplasm.